SCHEMBL9640528

SCHEMBL9640528

CC(C)OCCOCCOCCOCCOCCO

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
TSHR P16473 2/20 0.53
MAPK1 P28482 2/20 0.53
THRB P10828 1/20 0.44
HTT P42858 1/20 0.44
MAPT P10636 1/20 0.44
ALDH1A1 P00352 4/20 0.43
EPHX2 P34913 1/20 0.33
ADRB2 P07550 1/20 0.31
ADRB1 P08588 1/20 0.31
ADRB3 P13945 1/20 0.31
APP P05067 3/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
CYP3A4 P08684 1/20 0.30
CASP1 P29466 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
SLCO1B3 Q9NPD5 1/20 0.30
SLCO1B1 Q9Y6L6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3876514 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL1004316 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL9639228 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL9639782 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL9640265 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL9639247 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL157251 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL9640229 1.00 MEN1 (0.58) MEN1KMT2ATSHRMAPK1THRB
Isopropyl Alcohol SCHEMBL8326219 0.95 MEN1 (0.52) MEN1KMT2ATSHRMAPK1THRB
SCHEMBL8585424 0.91 MEN1 (0.48) MEN1KMT2ATSHRMAPK1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4871109-A PERFLUOROHEPTAGLYME; NONTOXIC MONSANTO COMPANY (US) 1989-10-03 US claimed
EP-0326539-A1 Vapor phase soldering using certain perfluorinated polyethers Monsanto Company (US) 1989-08-02 EP claimed
EP-4272825-A2 MTORC MODULATORS AND USES THEREOF Aeovian Pharmaceuticals, Inc. (US) 2023-11-08 EP disclosed
US-11702429-B2 mTORC modulators and uses thereof AEOVIAN PHARMACEUTICALS, INC. (US) 2023-07-18 US disclosed
US-11702429-B2 mTORC modulators and uses thereof AEOVIAN PHARMACEUTICALS, INC. (US) 2023-07-18 US disclosed
US-20230013344-A1 MTORC MODULATORS AND USES THEREOF EVOTEC (FRANCE) SAS (FR) 2023-01-19 US disclosed
US-20180140581-A1 METABOLICALLY PROGRAMMED METAL CHELATORS AND USES THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2018-05-24 US disclosed
US-8828261-B2 Electrolytic solution for aluminum electrolytic capacitor, and aluminum electrolytic capacitor using same PANASONIC CORPORATION (JP) 2014-09-09 US disclosed
US-20120235072-A1 ELECTROLYTIC SOLUTION FOR ALUMINUM ELECTROLYTIC CAPACITOR, AND ALUMINUM ELECTROLYTIC CAPACITOR USING SAME SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2012-09-20 US disclosed
US-5120459-A Functional fluids MONSANTO COMPANY (US) 1992-06-09 US disclosed
US-5076949-A Novel perfluorinated polyethers and process for their preparation MONSANTO COMPANY (US) 1991-12-31 US disclosed
US-4996369-A Perfluoroheptaglyme dimer; lubricants; heat exchangers; vacuum pump oils MONSANTO COMPANY (US) 1991-02-26 US disclosed
US-4871109-A PERFLUOROHEPTAGLYME; NONTOXIC MONSANTO COMPANY (US) 1989-10-03 US disclosed
EP-0332601-A1 Novel perfluorinated polyethers and process for their preparation Monsanto Company (US) 1989-09-13 EP disclosed
EP-0326539-A1 Vapor phase soldering using certain perfluorinated polyethers Monsanto Company (US) 1989-08-02 EP disclosed
US-4192759-A Automotive brake fluid compositions including semipolar borates and heteroborates TOHO CHEMICAL INDUSTRY CO., LTD. (JP) 1980-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702429-B2 mTORC modulators and uses thereof MTOR, RICTOR, RPTOR MEN1 1893/4885KMT2A 3291/4885TSHR 3270/4885
US-20180140581-A1 METABOLICALLY PROGRAMMED METAL CHELATORS AND USES THEREOF FECH, SLC19A1, SLC40A1 MEN1 741/4885KMT2A 2059/4885TSHR 1059/4885
US-20230013344-A1 MTORC MODULATORS AND USES THEREOF MTOR, RICTOR, RPTOR MEN1 1893/4885KMT2A 3291/4885TSHR 3270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.